According to the report, global demand for Glycomics/Glycobiology market was valued at approximately USD 910.08 million in 2018, and is expected to generate revenue of around USD 2,361.66 million by end of 2025, growing at a CAGR of around 14.64% between 2019 and 2025.
The report covers forecast and analysis for the Glycomics/Glycobiology market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Glycomics/Glycobiology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Glycomics/Glycobiology market on a global level. In order to give the users of this report a comprehensive view on the Glycomics/Glycobiology market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, application, end-user and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
Glycobiology is the science of carbohydrate structure, function and biology, also known as glycans. In every living organism, glycans are present. Glycobiology is a fast-growing biological area of interest to biomedicine, biotechnology, and basic research. Most proteins are modified post-translationally in eukaryotic cells. The attachment of glycans, or "glycosylation," is one of the most common modifications important to cell viability. Two forms of glycosylation exist: N-linked (the glycan is attached to an asparagine) and O-linked (the glycan is attached to a serine or threonine).
The study provides a decisive view on the Glycomics/Glycobiology market by segmenting the market based on product, application, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into enzymes, kits, reagents and instruments. Enzymes are expected to be the fastest growing segment on the global Glycomics/ glycobiology market due to its wide range of research & diagnostics applications and the repetitive purchase of these products. Based on application, the market is segmented into Drug Discovery & Development, Diagnostics and Others. Due to high demand for personalized medicines, drug discovery & production accounted for the largest revenue share in 2018 and concentrated on the development of new drugs.
Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and CROs. Due to increased spending in R&D, academic and scientific institutes accounted for the largest share of income in 2018. The expansion of the segment is further supported by cooperation between major organizations and institutes of study. The pharmaceutical and biotechnology segment is expected to record the highest CAGR during the preliminary period due to increased R&D investment in drug research, research and growth, and further glycobiology research.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. North America led the global glycomics / glycobiology market in 2018 and is expected to continue to dominate over the forecast period. The presence of a large number of research laboratories and pharmaceutical and biotechnology companies in North America is the key driver of the regional market.
Increasing discovery and development of medicines leads biotech companies to a rise in R&D investments. Consequently, the need for glycomics research techniques to perform a comprehensive study of glycomes is growing constantly. The increase in the number of government initiatives to increase funding for R&D has resulted in a growing need for glycomics techniques. It is expected that such funding measures would improve demand for glycomics research techniques in the near future. Extensive R&D initiatives are also undertaken by key companies to develop new and technologically advanced products.
Key players within global Glycomics/Glycobiology market include Agilent Technologies, Bruker, Danaher, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, Takara Bio, Inc., ThermoFisher Scientific, Inc., and Waters Corporation amongst others.
The report segments global Glycomics/Glycobiology market as follows:
Global Glycomics/Glycobiology Market: Product Segment Analysis
Global Glycomics/Glycobiology Market: Application Segment Analysis
Global Glycomics/Glycobiology Market: End-user Segment Analysis
Global Glycomics/Glycobiology Market: Regional Segment Analysis